Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Whitehawk Therapeutics, Inc. (WHWK)

Healthcare Biotechnology
3.90 $
+0.0% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Whitehawk Therapeutics, Inc. (WHWK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 41.6% of the shares are freely tradable; institutional investors hold 72.5%.

Ownership Structure

Institutional ownership
72.5%
Insiders
13.4%
Float
41.6%
Short % of float
4.3%
Shares Outstanding
50Mio.

Largest Shareholders

Institutions

Institutions WHWK
Name Stake (%) Shares Change (%) Date
Qvt Financial LP 9.33 4,615,709 +0.0 03/31/2026
Orbimed Advisors, LLC 8.42 4,166,000 +0.0 03/31/2026
Suvretta Capital Management, LLC 7.48 3,700,000 +0.0 03/31/2026
Longwood Capital Partners LLC 6.90 3,410,402 +0.0 03/31/2026
venBio Select Advisor LLC 5.76 2,849,402 +0.0 03/31/2026
KVP Capital Advisors, LP 4.38 2,165,997 +0.0 03/31/2026
Siren, L.L.C. 4.21 2,082,000 +0.0 03/31/2026
Yu Fan 4.19 2,070,000 +0.0 03/31/2026
StemPoint Capital LP 3.80 1,878,738 +28.8 03/31/2026
Vanguard Group Inc 3.22 1,590,117 +18.4 12/31/2025

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
14. May 2026 Dalal Anupam Director Other 1,275,510 3.92 4,999,999

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?